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Abstract (300 w) 
Despite the success of automated pattern recognition methods in problems of human brain 
tumor diagnostic classification, limited attention has been paid to the issue of automated data 
quality assessment in the field of MRS for neuro-oncology. Beyond some early attempts to 
address this issue, the current standard in practice is MRS quality control through human 
(expert-based) assessment. One aspect of automatic quality control is the problem of detecting 
artefacts in MRS data. Artefacts, whose variety has already been reviewed in some detail and 
some of which may even escape human quality control, have a negative influence in pattern 
recognition methods attempting to assist tumor characterization. The automatic detection of 
MRS artefacts should be beneficial for radiology as it guarantees more reliable tumor 
characterizations, as well as the development of more robust pattern recognition-based tumor 
classifiers and more trustable MRS data processing and analysis pipelines. Feature extraction 
methods have previously been used to help distinguishing between good and bad quality spectra 
to apply subsequent supervised pattern recognition techniques. In this study, we apply feature 
extraction differently and use a variant of a method for blind source separation, namely Convex 
Non-Negative Matrix Factorization, to unveil MRS signal sources in a completely unsupervised 
way. We hypothesize that, while most sources will correspond to the different tumor patterns, 
some of them will reflect signal artefacts. The experimental work reported in this paper, 
analyzing a combined short and long echo time 1H-MRS database of more than 2000 spectra 
acquired at 1.5T and corresponding to different tumor types and other anomalous masses, 
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Introduction  
Scant attention has been paid to the issue of automated data quality assessment in the field of 
MRS for neuro-oncology (1) and, although recent studies have started addressing this issue, 
often using supervised pattern recognition (PR) approaches, the current standard in practice is 
quality control through human assessment (2). One reason for this may be the lack of the type 
of biocuration standards that begin to be common in other life sciences fields such as genomics 
and, to a lesser extent, proteomics (3). Further reasons include the fact that MRS data in this 
area are scarce and fragmented. Fragmentation is both geographical and institutional, as the 
effort of gathering multi-center and international data is hindered by different barriers. The 
clinical centers who are ultimately responsible for data acquisition have few obvious incentives 
to even partially transfer the control of their data to third parties, and such parties, who should 
be responsible for managing multi-center data, either do not exist or lack the ability to sustain 
such role in a long-term basis. Furthermore, efforts to gather and manage international 
databases often collide with local legal limitations for the transfer and sharing of this type of 
personal medical information. 
Having said this, it is also true that some research efforts have been made in order to address 
the problem of MRS automated quality control (AQC) and that this problem has been 
approached from different perspectives. Early concerns about issues of spectral quality in clinical 
MRS and the lack of standards for the definition of what makes a spectrum acceptable or not 
were, for instance, raised in (4). In this review, a list of possible artefacts, many of them difficult 
to detect even by expert visual inspection, was compiled; several quality assessment 
quantitative measures were put forward and a number of criteria for spectra rejection were 
formulated. The need for the definition of quality requirements and goals for 1H-MRS data, as 
well as for the implementation of measures to guarantee quality standards and the sustained 
management of data quality have recently been stressed in (2). 
Part of the spectra in the current paper were analyzed at a first level in (1), where the quality 
assessment concerned the immediate step after data acquisition by automatic determination of 
the signal-to-noise ratio (SNR) in a water-suppressed spectrum and of the line width of the water 
resonance (water band width, WBW) in the corresponding non-suppressed spectrum. Threshold 
criteria for the selection of spectra were then empirically determined and additional artefact 
detection was carried out by human visual inspection. 
In recent research (5), AQC was taken to a second level that uses previously validated databases 
(6-8) as a starting point. In that study, a range of different PR classifiers were trained to mimic 
human decision making about the quality of spectra from data transformed according to 
different feature extraction methods. To learn this task, the classifiers used original human 
quality ratings from both multi-center and local experts as training labels. Classifier performance 
was subsequently compared with variance in human judgment. This work was in turn inspired 
by a previous smaller-scale study (9) in which a least squares support vector machine was trained 




acceptable from unacceptable spectra. This AQC approach has been recently extended to clinical 
1H-MRSI information in (10), where a random forest (RF) classifier was trained on MRSI grids 
previously labeled as acceptable or non-acceptable by two expert spectroscopists and where, in 
order to account for potential intra-expert reliability effects, each of the spectra was labeled 
three times by each expert. A similar approach, also using RF as the classifier of choice, was 
earlier presented in (11). Note that all these approaches aim to replicate human decision in a 
data-based automated form, but do not attempt to assess quality dispensing with human prior 
assessment. 
An alternative approach to AQC attempted to distinguish potentially problematic spectra using 
an outlier analysis (12). A fully unsupervised manifold learning technique was used to model the 
data distribution and a shortlist of spectra that did not conform to it was obtained. This shortlist 
of quantitatively atypical cases was inspected by experts to distinguish between naturally 
atypical spectra and spectra with artefact related anomalies. The categorization of the artefacts 
in those singled-out cases was subsequently carried out individually and in detail by human 
experts. The purpose of our present study was to apply a totally unsupervised PR approach on 
the largest multicenter collection of single voxel (SV) spectra of brain tumors available to date, 
to identify artefactual MRS patterns in a way which is expert-interpretable. 
In this study, we use feature extraction in a different manner for the purpose of MRS AQC. The 
proposed approach is based on a method of the blind source separation family (to which ICA 
also belongs), namely Non-negative Matrix Factorization: NMF (13), and, more specifically, one 
of its variants known as Convex NMF: CNMF (14). NMF was originally developed (13) as a method 
for the estimation of the latent (unobservable) sources of image, but it can be used with any 
kind of signal assumed to consist on a combination of such sources. If applied to an MR 
spectrum, the goal is discovering the hidden signal sources whose weighted combination 
constitute it., be it tissue types or artefactual patterns. 
The rest of the paper is structured as follows: we first describe the dataset used in the 
experiments, which is the largest multicenter collection to date of SV brain tumor spectra at 
short and at long TE, obtained at 1.5T. Next, we report the experimental design, with a brief 
description of how the CNMF algorithm works, and how we designed the descriptive study and 
evaluated it. Then results for short time of echo (STE) and long time of echo (LTE) are shown 
separately and discussed. Finally, some conclusions are drawn, and possible future lines of 
research are outlined.  
Materials and methods 
Data acquisition and processing 
The data analyzed in this study are the same that were reported in detail in (5). In brief, these 
are SV spectra from human brain tumors, acquired in 1.5T scanners from three different 
manufacturers (GE, Siemens and Philips) and different scanner models during the period 1994-
2009. They were downloaded from the multi-center INTERPRET (6,8,15) and eTUMOUR (7) 
databases and processed with the INTERPRET data manipulation software (8,16) and 




included setting the region between [4.2, 5.1] ppm to zero values, and the final processed 
spectrum consisted of 512 frequency points. The total number of STE (20-32ms) spectra 
acquired with PRESS or STEAM, processed and available for further analysis was 1,180. The 
corresponding total number of LTE (135-144 ms) spectra acquired with PRESS was 977. For this 
study, the original quality ratings by expert spectroscopists were not used, although they were 
available with the data matrices from (5). Regarding the quality as assessed by the expert 
spectroscopists’ panels for STE, 982 spectra were deemed to be good and 198 bad quality 
spectra, whereas for LTE, 828 were deemed to be good and 149 bad (5) - see Table 1 for details. 
The available spectra correspond to the variety of pathologies gathered in the databases. The 
distribution of spectra by tumor type and echo time is shown on Table 1. Some of the artefacts 
known to be present in the spectra include (although are not limited to) low SNR and/or bad 
water suppression (5). For evaluation (see section further on), seven classes or superclasses 
(brain tumor groupings) were considered: low grade gliomas (including astrocytoma, 
oligodendroglioma and oligoastrocytoma of WHO grade II), aggressive tumors (which included 
glioblastoma and metastasis), meningioma, lymphoma, primitive neuroectodermal tumors 
(PNET), astrocytoma WHO grade III, abscess as well as normal brain, as in (8,16).  
 
Experimental design  
Sources or archetypical spectral patterns were extracted using CNMF (14). This method 
generalizes NMF by admitting negative values in the observed data. Note that some of the 
spectra in the database include inverted peaks with such negative values.  The optimal number 
of sources to be extracted is not known a priori (17). Although this would be a relevant problem 
in a more general experimental setting, it is not a relevant one in this study, as we are interested 
in the exploration of the existence of signal artefacts across a wide range of source number 
values. For this reason, a descriptive study extracting from 4 to 20 sources per TE was set up. 
Extractions start at 4 sources as the minimum necessary to maintain a correspondence between 
the sources (or groups of sources) and the main types of tissue, according to (17).  
CNMF works by factorizing the observed data matrix 𝑋 (of dimensions 𝐷 × 𝑁, where 𝐷 is the 
dimension of the data -512 points or spectral frequencies in our case- and 𝑁 is the number of 
samples: 1,180 spectra at STE plus 977 at LTE) into two matrices: 𝐹 (the matrix of extracted 
sources, of 𝐷 × 𝐾 dimensions, where 𝐾 is the number of sources -from 4 to 20 in the reported 
experiments-) and 𝐺 (the mixture or coding matrix, of dimensions 𝑁 × 𝐾, where the values in a 
column are the weights associated with a source or base vector for each spectrum). The product 
of these two matrices provides a good approximation to the original data matrix. It is important 
to note that the values in 𝐺 are all non-negative and, therefore, each spectrum can be seen as a 
weighted combination of sources acting as data centroids. Therefore, we are making the 
important assumption that an MR spectrum is the measurable manifestation of the weighted 
combination of non-directly measurable (hidden or latent) signal sources. Furthermore, 𝐹 is 
constrained to lie in the column space of the input data 𝑋, so that the CNMF formula can be 
written as in Eq. 1: 
𝑋± ≈ 𝐹𝐺+




where 𝐹 =  𝑋± 𝑊+. This leads to = 𝐺(𝐺
𝑇𝐺)−1 ;  the ± subscript represents a mixed-sign data 
matrix and the + subscript indicates that the matrix is non-negative.  𝑊 (of dimensions 𝑁 × 𝐾) 
is an auxiliary adaptative weight matrix that fully determines 𝐺.  
Matrix 𝐺 is also called the mixing matrix, as it holds the coefficients (or coding coefficients, CC) 
to recompose a specific data sample. The CC value of each column in the mixing matrix therefore 
provides us with an estimation of the degree of contribution of each of the sources to each 
reconstructed spectrum. Each spectrum 𝑖 (of 𝑁) is represented as the linear combination of the 
𝑘𝑡ℎ source (out of 𝐾) and the CC 𝐺𝑖, as described by Eq. 2: 
 𝑋𝑖 = 𝐹1𝐺𝑖1 + ⋯ +  𝐹𝑘𝐺𝑖𝑘 +  ⋯ + 𝐹𝐾𝐺𝑖𝐾    Equation 2 
NMF methods unavoidably converge to local minima. As a result, the NMF bases will be different 
for different initializations. In this study, we use the k-means++ algorithm (18) for initialization. 
CNMF is based on iterative update algorithms, just like the original NMF, in which the factors 
are updated alternately until convergence (19). The algorithm works as follows: 
Step 1: Initialize G and 𝑊. This is achieved here with the k-means++ algorithm, as in (18), aiming 
to ensure that the algorithm starts from values close to the actual data centroids. 






    Equation 3 
Where (∙)+ is the positive part of the matrix, where all negative values become zeros; and (∙)− is 
the negative part of the matrix, where all positive values become zeros. 






   Equation 4 
Ten repetitions were carried out for each of the 17 source extractions (from 4 sources to 20) at 
both TEs, since the extracted sources may vary because of the k-means++ initialization. This 
number of repetitions was considered to be enough to calculate the mean and standard 
deviation (STD) of the sources extracted.  
In order to calculate the mean and STD of the sources, we first grouped them by similarity. For 
this, the Pearson correlation coefficients between each source and all the sources at each 
repetition were calculated, and those with the highest coefficient values at each repetition were 
grouped together. The first extraction was chosen as starting point. The obtained sources were 
graphically represented to allow a first intuitive visual verification of their characteristics. As 
mentioned in the introduction, we hypothesize that some of the sources would be identified as 
artefacts, while others will describe prototypical tumor patterns or normal tissue, as the 




CNMF was implemented in Python language (20) and run either via Google Cloud Platform, or 
at the computer cluster at the Institut de Biotecnologia i Biomedicina (IBB) in Barcelona, Spain.  
Evaluation 
The obtained sources were first qualitatively explored by two members of the team who are 
expert spectroscopists (CA and MJS) and then quantitatively assessed according to different 
calculated measures with the purpose of finding an automated way to distinguish artefact 
sources. The quantitative measures include: 
 Pearson product-moment correlation coefficients (matrix 𝑅 in Eq. 5) between the means 
of each of the matrices created with the sources obtained over 10 repetitions 
(matrix 𝑌) and the means of the different tumor classes, abscesses and normal tissue 




 ,        Equation 5 
where 𝑐𝑖𝑖, 𝑐𝑗𝑗 , 𝑐𝑖𝑗  are elements of the covariance matrix 𝐶 of (Y, 𝑍). The values of 𝑅 
belong to the closed interval [−1,1]. This measure evaluates whether the extracted 
sources correlate with known prototypical spectra of different pathologies, or with 
healthy tissue. 
 Euclidean distances between the means of each of the matrices created with the 
sources obtained over 10 repetitions (𝑌) and the mean spectra of different tumor 
classes in the INTERPRET validated database (𝑍), calculated as ‖𝑌 − 𝑍‖2, evaluate the 
similarity between the extracted sources and the different prototypical spectra of 
different pathologies, or healthy tissue.  
 The CC of the mixing matrix (𝐺) of the means of each of the matrices created with the 
sources obtained over 10 repetitions (𝑌). These can be understood as estimates of the 
concentration/abundance of the constituent signals or sources in the conformation of 
each spectrum. These will help us to determine how well the sources obtained through 
convex NMF represent the artefacts.  
Results  
Here, we report some of the experts’ interpretations of the extracted sources. For the sake of 
brevity, only part of the complete set of results is reported, with some detailed results moved 





Figure 1 shows the mean and standard deviation (STD) of sources extracted for 𝐾 = 4 (minimum 
number of sources) at STE. Sources S1 and S4 show patterns that resemble those of high-grade 
glial tumors, characterized by the predominance of mobile lipids (0.9, 1.3 ppm). Source S3 is 
similar to low grade glial tumor spectra, in which there is an increase in the Choline peak, a 
decrease in Creatine and N-acetyl aspartate, and an increase in the Myo-inositol/Glycine peak, 
with respect to normal brain parenchyma pattern. Source S2, instead, can be considered as an 
artefact due to poor water suppression, which can be observed in the residual water signal 






Figure 2 widens the scope and shows the extractions from 𝐾 = 4 to 𝐾 = 8 (by rows) at STE. 
Sources in column 2 show the poor water suppression artefact, whereas in column 6 poor water 
suppression and negative intensities/bad water phasing can be observed. This should be 
considered as an artefactual source, given that spectra at STE are not supposed to have negative 
values. Column 8 shows a source that is compatible with a combination of artefacts: poor water 
suppression and spurious echoes (4). 
Figure 3 shows the extraction for the maximum of twenty sources. Table 2 displays the 
consensus expert spectroscopists’ evaluation. It can be observed that sources S1, S4, S7, S9, S14 
and S15 are compatible with high-grade tumors, which is related to the presence of mobile lipid 
peaks at 0.9 and 1.28 ppm. Amongst these, S9 shows an uncommon high methyl resonance at 
ca. 0.9 ppm, compatible with the spectral pattern of some oligodendrogliomas (21,22).  S11, S17 
and S18, even if still interpretable, contain artefactual patterns mainly due to insufficient water 
suppression- in particular for S2, S5, S10, S12, S13, S16 and S20 show clear artefactual patterns, 
and S18 is borderline regarding this aspect. It appears that the problem in most them is bad 




suppressed water signal, rarely used for classifier development. It can also be seen that more 
than one artefact coexists in some instances, for example low SNR (S2, S13) and spurious echoes 
(S2, S13). The remaining sources have characteristics that match the type of patterns of known 
tumors, as in S3 or S18, which are compatible with meningioma; S6, with low grade glioma; S8, 
with PNET or astrocytoma grade III, and S19, with normal brain. Importantly, all these sources 
consistently appear and also show little variability throughout all extractions (𝐾 = 4, … ,20).  
With  
 
Figure 4, we now move to similar experiments for LTE data sources. It includes the results for the 𝐾 = 4 extraction, 
where S1, S2 and S3 display good quality patterns, while S4 clearly corresponds to a bad water suppression artefact. 
S1 and S2, though, also show a small contribution from incomplete water suppression. 
Figure 5 displays extractions from four to eight sources. It can be observed again that some of the sources appear 




when more sources are extracted. 
 
Figure 6 shows the extraction for 𝐾 = 20 at LTE, where it can also be appreciated that only S3, 
S12 and S13 show low variation, while the rest of sources show different degrees of variability. 
Such variability can be assessed in detail from  
 
Figure 7, which shows, for STE and LTE, the standard deviation of the different sources in the 
form of box-plots. These plots provide evidence that the 4-source extraction is the less variable 
whereas the solutions obtained with the 20-source extraction are rather unstable, although 




variability (S12, S17, S5, S20). Additionally, the standard deviation of the 20-source extraction 
solutions at STE is clearly lower than at LTE.  
Supplementary Figures 1 to 22 provide the details of the standard deviation for all the 
extractions at the different TEs, where it can be noted that either 4 or 5 sources at STE and 4 at 






Figure 8 and 
Figure 9, for STE and LTE respectively, show the correlations and Euclidean distances between 
the sources obtained at 𝐾 = 20 and the different mean spectra from the INTERPRET database, 
as well as the CCs. Tables 2 and 3 summarize the results of the different criteria for 𝐾 = 20 from, 
in turn, data acquired at STE and LTE. As it can be observed, most artefactual sources do not 
correlate (Pearson < 0.50) with at least one of the compared types; there is a high Euclidean 
distance between the sources and the compared types and there are no samples with CCs higher 
than 0.75. The experts also considered that the above-mentioned patterns were artefactual or 
contained artefacts, in particular for STE. 
Figures in the Supplementary materials show the equivalent results for 𝐾 = 9, …, 19, at STE and 
LTE. 
Discussion 
In this study, we extracted characteristic spectral patterns in a wholly unsupervised way, i.e. 
disregarding instrumental quality or tumor type labels. The mathematical approach chosen was 
CNMF, on the assumption that the observed spectra are the result of a combination of 
unobserved signal sources.  
An alternative approach could have been to apply a technique such as ICA. ICA restricts the 




affect the probability of occurrence of the other), leading to MRS sources that poorly resemble 
the tissue types involved (23). For this reason, even when ICA has been extensively used to 
remove artefacts from electroencephalographic recordings (24), we did not consider it our first 
choice for extracting the kind of artefacts that can be found in MRS data. The non-negativity 
constraints of NMF, instead, lead to a parts-based representation because they allow only 
additive, not subtractive, combinations. This parts-based representation is key to explain the 
success of this BSS method in MRS data. ICA learns holistic (i.e. the whole rather than the sum 
of its parts) instead of parts-based representations. Amongst NMF variants, we chose to use 
CNMF as 1) it applies to both nonnegative and mixed-sign data matrices (key for long time of 
echo –LTE- MRS data),), 2) it has proven to represent better the underlying signals in the data 
(25,26) as the sources must lay in the convex hull of the data, and 3) CNMF is bound to generate 
sparse mixing matrices (with many elements taking values close to zero), which is a very useful 
property that can be exploited in future work in the artefact removal process. The use of NMF 
and CNMF for the analysis of MRS has already been reported in the field of neuro-oncology (25-
28).  These methods have mostly been used to detect sources that might be related to specific 
tissue types in and around the tumor, accounting for the spatial co‐existence of tissue types.  
Here, the use of CNMF had quite different goals. We hypothesized that, should some of the 
analyzed MRS data be contaminated by errors in the form of artefacts of different type, some 
of the sources extracted by CNMF should mostly reflect such artefacts, while the rest of sources 
would mainly reflect true tissue information. If this hypothesis holds, it follows that the MRS 
data could be adequately reconstructed from only those sources containing true signal, by 
removing the artefactual sources from the reconstruction.  
As the number of underlying sources in the dataset is not known a priori, we performed a 
descriptive study extracting from four to twenty different sources from the available spectra. 
Note that the criteria to choose the most appropriate number of sources may be based on 
strictly quantitative measures, on the radiological interpretability of the extracted sources, or 
on a trade-off between both approaches. This was not the objective of the current study and, 
therefore, such number remains to be determined. To address this problem, for example, 
Laruelo (29) used vertex component analysis (30), Vilamala et al. used a Bayesian NMF variant 
(31), and, in (32), the authors proposed an approach to automatically discard irrelevant sources 
during the iterative process of matrices decomposition. However, in terms of source extraction 
stability and according to the reported results, choices of 𝐾 = 4 − 5 for STE and 𝐾 = 4 for LTE 
seem optimal to represent major tissue and artefact classes.  
The experiments were carried out on the largest multicenter SV MRS brain tumor patient 
database available to date. The results reported in the previous section clearly indicate that 
some of the sources appear consistently across extractions, no matter the number of sources 
extracted, and that they correspond to well-defined sources (in the sense that they clearly 
correspond to either tumor types or to artefacts). The artefactual patterns are mostly different 
shapes of bad water suppression, as well as low SNR. The bad water suppression artefact is the 
most conspicuous and appears even in the extraction of only four sources. A recent work by 




model) to detect the ghosting artefact (4), which is very difficult to classify with conventional 
methods. It is difficult to ascertain whether CNMF is as good as deep learning in detecting this 
kind of artefact. The spectra we used in this work were already defined on the frequency 
domain, so a detailed analysis of the cause of each artefact was out of the scope of our study. 
Also, the dataset we used contains a wide variety of artefacts, sometimes more than one in each 
spectrum (e.g. bad water suppression and ghosting artefact), in contrast to (33), where the 
authors used simulated and in vivo volunteers’ spectra in which, purposely, the only artefact 
was the ghosting one. It remains to be tested whether a deep learning approach would also be 
as good as CNMF to chase other kinds of artefacts, but at any rate these two approaches seem 
to be complementary. Recent work by Gurbani et al. (34), using CNN, seems to suggest so, as 
their algorithm was able to pick artefactual patterns of different origins with remarkable 
efficiency (AUC of 0.95 in the test set). Their dataset was composed of 8,894 spectra from only 
nine patients. 
One of the hypotheses in our study was that some of the sources extracted by CNMF should 
mostly reflect known artefacts, while the rest of sources would mainly reflect true tissue 
information. The results reported in figures 1 to 6 support this hypothesis to a large extent, as 
artefactual sources were easily identified and characterized by spectroscopy experts. 
Furthermore, these sources repeatedly and consistently appeared with small variants in every 
extraction from 4 to 20 sources. Most importantly, the quantitative measures support the 
experts’ proposals. The results for data acquired at STE reported in Figure 8 provide us with a 
detailed picture. Out of the 20 extracted sources, S2, 5, 10, 12 and 16, identified as artefactual, 
have very low correlations and corresponding high Euclidean distances with all types included 
in the databases (tumors, abscesses and normal tissue). They also show low CC values, which is 
consistent with the fact that they only weight strongly on a limited number of spectra. On the 
other hand, non-artefactual sources show overall high correlations and low Euclidean distances. 
Moreover, some sources correlate highly with specific profiles. For instance, S1, 7, 9, 14 and 15 
highly correlate with both abscesses and aggressive tumors, while S19 correlates highly with 
normal tissue. Note that the CC values offer some further interesting insight: those sources with 
the highest number of values over the 0.75 threshold are precisely the less variable and best-
defined ones, corresponding quite neatly to database types. A similar analysis could be 
presented for the data acquired at LTE, but we omit it here for the sake of brevity. 
When only a few sources are extracted, they are more likely to be combinations of more basic 
sources and these combinations tend to break into more basic components as the number of 
sources increase. Related to this, we found that the instability of the sources globally increased 
as the number of extracted sources increased. This is no surprise, as the uncertainty of the 
results is bound to increase for more sources when the number of spectra remains the same. 
Note though that this variability is by no means homogeneous over the extracted sources, with 
some of them showing very low variability. What is more, some sources show high variability in 
some frequency ranges and low variability in others. This is visually clear from figures 1 to 6, but 
also quantitatively from the boxplots of Figure 7. Artefactual sources have, in general, more 




spectra and have limited leverage on the rest. A few of the non-artefactual sources also show 
high variability, which might be a sign of their low impact in the overall signal.   
In the past, most efforts towards quality control of MRS data have been based on supervised 
approaches that are known to have some limitations. Each spectrum had always been treated 
as either being of good quality or bad quality. Then a bad quality spectrum would be so, 
irrespective of the cause (the artefact) and the magnitude of the problem: as an extreme 
example, a slightly badly phased spectrum could end up in the same category as an extremely 
noisy spectrum, or one with bad water suppression and a very important problem with the 
phasing as well as with small peaks in the frequency region of interest, all artefacts at the same 
time. Therefore, one limitation to this approach is the evident fact that labelling depends on 
experts, and different experts may have different thresholds for accepting a spectrum based on 
its quality. This was extensively recorded in the same source database where the current dataset 
has been taken from (6-8), but never systematically studied. Nevertheless, the fact has always 
been duly acknowledged in all previous studies (for example in (5), to cite just one recent study).  
Another related limitation to supervised approaches is the mere existence of a diversity of 
artefacts, ranging from low SNR to bad water suppression, ghosting, bad or imperfect phasing. 
Kyathanahally et al. demonstrate this fact graphically in Figure 1 of their publication (5), where 
it can be seen that the means and standard deviations of good quality spectra and bad quality 
spectra clearly overlap, leaving approaches such as those based on linear discriminant analysis 
unsuitable for the task, a fact known since early work (1), where a quadratic discriminant 
classifier was employed instead.  
Supervised approaches, in the end, require a simplified labeling setting to which an unsupervised 
approach such as CNMF is not restricted to. For this reason, sophisticated classifiers such as 
those from the deep learning family (34) are only suitable for such simplified setting, in which 
they can achieve very competitive results. A word of caution must be given though, as deep 
learning methods are only meant to provide a neat advantage in data rich settings, which are 
uncommon in the MRS(I) domain. An example of that are the excellent results recently obtained 
by alternative classifiers in a similar setting  (5) without resorting to deep model architectures, 
but to a boosting and data sampling method (RUSBoost (35)) specifically suited to class-
imbalanced data sets.  
An unexpected finding of our study has been that, when there is a sufficiently high number of 
sources, we begin to observe patterns that are partly usable and partly unusable (for example 
see Figure 3, STE, source 18, region downfield from water). In fact, for 20 sources extracted at 
STE, there appears to be a total coincidence when the experts consider a source as artefactual 
and, 1) its Pearson’s correlation with at least one of the compared classes is higher than 0.50, 2) 
the Euclidean distance between this source and all the means of the different classes is lower 
than 100 and, 3) none of the spectra in the database has a CC higher than 0.75. However, results 
for LTE are not as clear-cut, mainly because there are some examples of these “partially 




Altogether, evaluating the sources with three different quantitative measures appears to be a 
valuable approach, as in clear-cut artefacts all measures would agree, while in partially valid 
spectra there might be disagreement between these measures, should a threshold for decision 
be established. Gurbani et al. (34) used an approach named GRAD-cam (36), and they were able 
to identify that the most artefactual regions (approximately [0, 1.6] and [3.7, 4.5] ppm) were 
those out of the main interesting metabolite regions. Despite their spectra having a narrower 
spectral range than ours ([0, 4.5] ppm vs [-2.7, 7.1]), their results point to their CNN being able 
to at least recognize bad water suppression and bad homogeneity, although exclusion of spectra 
with a metabolite linewidth greater than 18 Hz had been performed before the experiment.   
The fact that NMF methods “pick” artefacts, as well as metabolically-interesting patterns, has 
been known since the first application of this technique to MRS data of humans (figure 9 in (37)), 
and has recently been corroborated (figure 7.7 in (29)). However, this fact is usually overlooked, 
other than for the need of getting rid of the artefacts. One simple strategy used by Sajda et al. 
(37) was to remove artefactual sources (recognized by the expert spectroscopists) from 
subsequent analyses by a masking procedure. Another useful approach when artefact detection 
is not the objective is to discard bad quality spectra before performing further data analyses, for 
instance using well-established threshold criteria as in (17,19,27,38,39), and/or by using 
integrated peak areas of selected metabolite intensities (40,41).  
As for our results, artefacts are conspicuous, indefectibly appearing when asking even for the 
lowest number of sources (𝐾 = 4). In this sense, unsupervised CNMF is shown to be a powerful 
tool for this kind of imbalanced datasets (a high number of good quality spectra and a low 
number of bad quality spectra), for which the adoption of an oversampling schema for the bad 
quality spectra class (5,34) is advisable for supervised approaches to perform optimally. 
Another question that can be raised in view of the results presented in this study and others 
addressing similar issues is: are some PR approaches best suited to detect one particular type of 
artefact than others? This question merits further in-depth research. 
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Figure 1. Mean and STD (+/-) of sources (S) extracted for K=4 (K being number of sources) from spectra acquired at 
STE (N=1,180). S1, S2, S3 and S4 stand for source number 1, 2, 3 and 4, respectively. The x-axis of the graph is 
represented in parts per million (ppm), while the y-axis represents the intensities in arbitrary units (a.u.). The mean 
is represented by a blue line and the variability described as STD (+/-) is displayed in gray shade, enclosed by a black 
line. In this source extraction, variability is extremely low, which explains why only a single black line seems to 
represent the source. The sources closely resemble characteristic spectra of different types, and could even be taken 
by a mean spectrum if no more information was given. As the original spectra had been processed with the INTERPRET 
pipeline {Tate, 2006 #15942}, which includes a residual water suppression from points between 4.2 to 5.1 ppm set to 
zero prior to unit length normalisation, sources also display this characteristic of the processing pipeline. The zeroing 
of the 4.2-5.1 ppm interval was incorporated into the INTERPRET pipeline because if there were any remnants of 
water signal, the intensity of the rest of the spectrum would be affected when performing the unit length 
normalization. 
The first and third sources (S1 and S3) have a typical pattern of necrosis with high lipids at 0.9, 1.28 and 2 ppm, with 
S4 additionally showing choline-containing compounds at 3.21 ppm and lipids at 5.3 ppm, and a different 
methyl/methylene (0.9ppm/1.28ppm) ratio than for S1. S2 shows a typical pattern of bad water suppression, that the 
zeroing between 4.2 and 5.1 could only partially eliminate, therefore the appearance of these two “tails”, from the 
incompletely suppressed water signal, appearing between 3.9 and 4.2 approximately and between 5.1 and 7.1 ppm. 
No other metabolite signals can be identified in this S2. The third source (S3), shows the typical pattern for an 
infiltrative, low-grade glial tumour, in particular the high choline-containing compounds / creatine ratio 
(3.21ppm/3.03ppm) is indicative of high proliferation, whereas the decrease in the intensity of the N-acetyl-
containing compounds at 2.01 ppm (it should be about twice the height of the creatine peak in a normal brain) is 






Figure 2. Mean and STD (+/-) of sources extracted at STE, for K=4 to K=8, from spectra acquired at STE (N=1,180). Each 
row corresponds to a different source extraction, starting with K=4 at the top. Columns were organized according to 
the similarity of the sources. Columns 1, 2, 3 and 4 correspond to sources that have similar characteristics to the ones 
for K=4. Other features as in figure 1 legend. 
 
Figure 3. Mean and STD (+/-) of sources extracted for K=20 from data acquired at STE (N=1,180). Again, the mean is 





Figure 4. Mean and STD (+/-) of sources extracted for K=4 from data acquired at LTE (N=977). Representation as in 
previous figures. 
 
Figure 5. Mean and STD (+/-) of sources extracted from data acquired at LTE (N=977). Each row corresponds to a 
different source extraction from K=4 to K=8. Columns were again organized depending on the similarity of the sources. 










Figure 7. Boxplots of the STD values for the ten algorithm run repetitions and for each of the sources in two different 
extractions (K = 4 and K = 20) from data acquired at STE and LTE; (The box extends from the lower to upper quartile 
values of the STD, with a line at the median. The whiskers extend from the box to show the range of the data. (Outlier 
points are those past the end of the whiskers). STD was calculated from the matrix in which there are ten rows 






Figure 8. a) Correlation between sources extracted for K=20 (from data acquired at STE) and mean spectra from the 
types included in the INTERPRET validated database (6), where the x-axis corresponds to the source number and the 
y-axis to the values of the correlations. b) Euclidean distance between each source for the K=20 extraction (from data 
acquired at STE) and mean spectra from the types included in the INTERPRET validated database (6), where the x-axis 
again corresponds to the source number, while the y-axis corresponds to Euclidean distances. c)  CC of the mixing 












 STE LTE 
Type GOOD  POOR  BAD  Total GOOD  POOR  BAD  Total 
Abscess 9 0 2 11 8 1 2 11 
Astrocytoma WHO grade III 7 0 0 7 7 0 0 7 
Lymphoma 16 2 1 19 15 0 3 18 
PNET 11 0 0 11 8 0 0 8 
Glioblastoma 
Aggressive 
189 5 18 212 215 9 34 258 
Metastasis 87 1 7 95 78 4 10 92 





68 2 7 77 60 7 4 73 
Oligodendroglioma  27 0 2 29 39 2 2 43 
Oligoastrocytoma  12 0 3 15 22 1 1 24 
Pilocytic astrocytoma 27 1 9 37 37 1 9 47 
Other Pathologies 100 19 10 129 156 25 3 184 
Not available 304 23 55 382 77 1 12 88 
Total 982 49 149 1180 828 38 111 977 
Table 1. Number of spectra, acquired at STE and LTE, available per tumor type and quality label. The GOOD, POOR 
and BAD labels are taken from the data matrix from study (5), in which the the intermediate label of “poor quality” 
was assigned to the rejected spectra that had been seen by three experts and had been accepted by one of them.  












Pearson correlation > 
0.50 at least with one of 
the compared classes 
Euclidean distance with 
all the compared 
classes, at least > 100 
Number of 
samples with 
CC > 0.75 
1 Good quality Yes No Several 
2 Artefactual pattern No Yes None 
3 Good quality Yes No Several 
4 Good quality Yes No Several 
5 Artefactual pattern No Yes None 
6 Good quality Yes No Several 
7 Good quality Yes No Several 
8 Good quality Yes No Several 
9 Good quality Yes No Several 
10 Artefactual pattern No Yes None 
11 Good quality Yes No Several 
12 Artefactual pattern No Yes None 
13 Artefactual pattern Yes No Several 
14 Good quality Yes No Several 
15 Good quality Yes No None 








Yes No Several 
19 Good quality Yes No Several 
20 Artefactual pattern No Yes None 











0.40 at least 




distance with all 
the compared 




with CC > 
0.75 
1 Good quality Yes No None 
2 Artefactual pattern No Yes None 
3 Good quality Yes No Several 
4 Artefactual pattern No Yes None 
5 
Artefactual pattern but source too variable 
to be sure 
Yes No  Several 
6 
Good quality but source too variable to be 
sure 
Yes No Several 
7 Partly artefactual pattern 
No (close for 
low grade 
glial) 
No  Several 
8 Artefactual pattern No Yes Several 
9 Artefactual pattern Yes No Several 
10 Artefactual pattern No No None 
11 Artefactual pattern No No None 
12 Good quality Yes No Several 
13 Good quality Yes No Several 
14 
Artefactual pattern, but source too variable 
to be sure 
Yes No Several 
15 Artefactual pattern No Yes None 
16 
Partly artefactual pattern but source too 
variable to be sure 
Yes No Several 
17 Partly artefactual pattern No Yes None 
18 
Partly artefactual pattern but source too 
variable to be sure 
Yes No Several 
19 Good quality Yes No Several 
20 Artefactual pattern No Yes None 
Table 3. Summary of the evaluations for the 20-source extraction, at LTE. For some sources, the evaluation is 
uncertain (source too variable), because there is so much variability that one of the 10 solutions may be the actual 
reverse of the evaluation.   
